Pneumatic Nebulizers Market: Rapidly Evolving Industry…… COVID-19….


The global pneumatic nebulizers market size was valued at USD 490.6 million in 2015 and is expected to reach a value of USD 893.9 million by 2025. The expansion is attributed to the increasing geriatric population base along with the growing need for home healthcare portable devices. The introduction of new systems featuring aerosol drug delivery technology with minimal drug wastage is expected to drive the market growth. For instance, in May 2013, Parion Sciences in partnership with Cambridge Consultants developed a technology that delivers tiny saline droplets that infiltrate deep into the lungs. The trans-nasal pulmonary aerosol delivery device currently undergoing clinical trial is intended for the treatment of cystic fibrosis.
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
Moreover, with the rising rate of hospital admissions and the resultant high expenditure, companies are encouraged to introduce home care devices that enable pre-hospitalization monitoring. Furthermore, the advent of integrated devices has empowered patients and physicians to share and access data on a single platform.
For instance, in March 2016, Philips received 510 (K) clearance for its Care Orchestrator. The cloud-based technology is a clinical management software, which promotes homecare for sleep apnea and respiratory care patients. Moreover, the clinical management system furnishes a single platform combining sleep and respiratory care, providing informatics and workflow intelligence for patients, providers, and payers.
Some of the major players operating include Omron Corporation, Philips Healthcare; PARI Pharma GmbH; GE Healthcare; Allied Healthcare; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; and Briggs Healthcare.
To Request Sample Copy of this report, click the link:
Further Key Findings from the Study Suggest:
·         Vented nebulizers dominated the product type segment in 2015 owing to their high availability and affordable cost. Moreover, industry contributors are introducing new solutions that enable patient data access in one single platform. In November 2015, CareFusion introduced a new respiratory solution at the American Association for Respiratory Care Congress.
·         North America is estimated to dominate the pneumatic nebulizers market in 2015. The introduction of advanced technological devices and the supportive medical coverage offered in this region is expected to further fuel market growth. For instance, in March 2015, Sunovion Pharmaceuticals, Inc. announced the initiation of Phase III clinical trial for its SUN-101 solution using PARI Pharma’s eFlow nebulizer system for COPD.
·         Asia Pacific is the fastest growing market owing to its huge aging population base, increasing focus on preventive care, and government initiatives promoting technological innovations. In July 2015, Tribeca Care launched its online healthcare store to supply homecare respiratory products, wherein prominent medical brands such as Philips, Omron, Nidek, Karma, ResMed, and Vissco were brought under one roof.
·         Sector players are integrating healthcare with technology to improve upon the current patient monitoring devices in the vertical for respiratory diseases. Moreover, increasing awareness around pre-assessment devices has further accelerated the demand for pneumatic nebulizers. In June 2016, Philips introduced the Patient Adherence Management Service at the 2016 SLEEP event to better patient compliance to sleep therapy.
The global pneumatic nebulizers market size was valued at USD 490.6 million in 2015 and is projected to grow at a CAGR of 6.2% over the forecast period. The high growth is attributed to the rising demand for non-invasive methods of drug delivery, increasing incidence of various respiratory disorders, and the surging geriatric population.
The increasing incidence of respiratory diseases is a vital impact rendering factor supporting the growth of this sector. In 2011, according to the American Lung Association, around 10 million Americans suffered from chronic bronchitis. Moreover, the chances of developing chronic bronchitis increases with age as it was determined that out of those 10 million cases around 70.0% people were above 65 years of age.
Nebulizers are electrically powered or battery-operated devices used to administer liquid drug in the form of mist and aerosol. The increased surface area yields a better drug therapeutic effect as compared to inhalation therapy.The device is used to treat various respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and cystic fibrosis. Moreover, the increasing application of pneumatic nebulizer as a method for treatment of diabetes, migraine, and cancer is expected to drive the demand for pneumatic nebulizers.
Browse Press Release of this report:
Government initiatives and organization funding deployed to improve the current treatment alternatives for respiratory conditions are also expected to result in an upsurge in the demand for inhalation devices.The American Heart Association along with National Association for Stock Car Auto Racing (NASCAR) launched a DRIVE4COPD campaign in 2011. Through this partnership, NASCAR was responsible for screening around three million NASCAR fans for COPD.
Another initiative expected to positively influence the market, is the COPD population screener by the COPD Foundation. Using this screener, Americans citizens who are 35 years and older are screened for COPD through a five-question test. If the screener indicates positive results, the individual is advised to visit a healthcare professional or call the COPD helpline, thereby raising awareness among the population to enable early intervention.
Grand View Research has segmented the global pneumatic nebulizers market by type:
Pneumatic Nebulizers Type Outlook (Market revenue in USD Million, 2014 - 2025)
·         Vented Pneumatic Nebulizer
·          Breath-Actuated Pneumatic Nebulizer
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.




Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..